Magnetic Resonance Imaging Diagnostics of Vascular Myelopathies: from Basic Sequences to Promising Imaging Protocols

Cover Page


Cite item

Abstract

Magnetic resonance imaging (MRI) is the method of choice in diagnostics and differential diagnosis of spinal cord arterial infarction and venous insufficiency. However, imaging of vascular myelopathy is complicated by the lack of clear diagnostic criteria. Basic MRI sequences have low sensitivity at disease onset, and described MR patterns do not sufficiently increase imaging specificity for spinal cord ischemia, so imaging protocols are to be elaborated.

Diffusion-weighted imaging is a key additional sequence that allows establishing the ischemic nature of myelopathy.

Inclusion of spinal MR angiography in comprehensive MR examination allows visualization of aorta abnormalities, its large branches or spinal arteriovenous fistulas, so that they can be treated early.

We presented an optimal MRI protocol for patients with suspected ischemic spinal stroke. Promising high-tech MR sequences for visualization of vascular myelopathies were reviewed.

Full Text

A search for effective methods for diagnosing myelopathies to differentiate various mechanisms of spinal cord (SC) damage has been ongoing for decades. The imaging methods that were described and introduced in the second half of the 20th century, such as angiography, expanded our understanding of blood supply to the SC and vascular myelopathies [1]. Widespread introduction of magnetic resonance imaging (MRI) into clinical practice and use of various MRI modalities and sequences have revealed many differential diagnostic aspects of central nervous system damage [2–4]. However, most MRI protocols that are successfully used for diagnostics of brain lesions are not used for myelopathies due to the anatomy and physiology of the SC. At the same time, development of neuroimaging methodology and consistent accumulation of knowledge about the pathophysiology of non-compressive vascular myelopathies allows considering the capabilities of MR technologies from new perspective.

Supplementing the definition proposed by the American Heart Association [5], we can say that ischemic spinal stroke (acute SC infarction, subheading G95.1 “Vascular myelopathies” of ICD-10, subheadings 8B43 “Non-compressive vascular myelopathy” of ICD-111) is a severe damage of the SC substance that is manifested by a sudden or rapidly increasing persistent neurological deficit, which is established based on pathological, imaging, or other objective evidence of SC focal ischemic injury in a defined vascular distribution if other intra- or extramedullar abnormalities are excluded. Therefore, the current model for diagnosing vascular myelopathy is based primarily on the rapid exclusion of other acute myelopathies that require immediate surgery (such as compressive myelopathy, SC tumors) or conservative treatment (such as myelitis) [6, 7]. In other words, "vascular myelopathy” is still a diagnosis of exclusion.

Unfortunately, we do not have exact epidemiology data available on prevalence of SC vascular disorders. Rare publications on this topic reported a few studies with small sample size and heterogeneous inclusion criteria. According to them, vascular myelopathies account for 5% to 8% of all acute myelopathies and 1% to 2% of all vascular neurological pathologies [8]. A.I. Qureshi et al. in a population-based study suggested that the incidence may vary from 1.6 to 7.2 per 100,000 person-years [9].

The lack of uniform diagnostic protocols may be a reason for a relatively small number of registered cases of vascular myelopathy. Therefore, we can assume that patients with SC infarction are often misdiagnosed. The lack of diagnostics criteria has also hampered overall progress in spinal angioneurology [10]. However, early diagnostics of SC infarction is crucial for identifying and eliminating potentially manageable causes, as well as early initiation of rehabilitation measures [11].

Both clinical and imaging signs of vascular myelopathy largely depend on the mechanisms and causes of SC hypoperfusion, which are associated with either reduced arterial blood supply or venous dysregulation [12].

Most common causes of arterial spinal cord infarction (SCI) include aortic disease (atherosclerosis, dissection, coarctation), vertebral artery disease, atherosclerosis and mechanical compression of the radicular arteries, and hypotension due to heart failure [13–15]. According to various authors, the proportion of idiopathic SCI varies from 7% to 50% [8, 16]. Venous congestion due to abnormal arteriovenous shunts in the presence of spinal dural or epidural arteriovenous fistulas is a major cause of spinal venous insufficiency [6].

Iatrogenic causes of SC infarction should be mentioned separately. According to N.L. Zalewski et al., aortic aneurysm repair is the most common procedure that is complicated by SCI (49% of cases) [17]. Other surgical interventions and procedures on the aorta account for 15% of cases; surgical and manual procedures on the spine, endovascular surgery, epidural anesthesia, and blockade of the cervical or lumbar roots of the spinal cord account for 36%.

It should be also noted that the studies mainly included patients after aortic surgery. Therefore, the pathogenesis and natural history of spontaneous or non-iatrogenic SC infarction remain largely unknown [18].

Thus, neuroimaging is a pivotal diagnostics step because it allows narrowing differential search and establishing a specific diagnosis.

Aim. This review aimed at summarizing available information on the sequences and MRI markers that are used in diagnostics of vascular myelopathies.

Materials and methods

A review of publications indexed in PubMed, Scopus, and RSCI databases was carried out using the key words “spinal cord”, “ischemia”, “infarction”, “non-compressive myelopathy”, “MRI”, “sequences”, “DWI”, “DTI”, “spinal angiography”, “vascular malformations”.

MRI methods for visualization of ischemic spinal stroke

Due to physical limitations of X-ray diagnostic modalities and spatial resolution of computed tomography (CT), MRI has become the gold standard for visualization of vascular and other lesions of the spinal cord. Crucial for a good-quality spinal examination is the use of magnetic resonance scanners with optimal spatial resolution and signal-to-noise ratio (SNR) [19].

However, available spine and SC MR protocols are less standardized than those for brain imaging. Spinal “visualization barriers” are most challenging for sequence optimization. Artifacts caused by lung excursion and respiratory movements of the chest, CSF dynamics and aortic pulsation, swallowing, can lead to distortion of MR images to a certain extent [17–19].

In addition, 3T MR scanners for SC imaging compared with 1.5T ones are more prone to artifacts caused by field inhomogeneity [20].

However, there are sequences that are used for any spine MRI protocol. These sequences are fast spin echo T2 and spin echo T1; investigations should have sequences in both sagittal and axial planes in the field of view that does not exceed the area of interest and slice thickness of up to 3 mm, which helps identify the exact location of the lesion [21].

Widely used in spinal neurology, T2-weighted imaging (WI) with the spin-echo inversion-recovery method (Short-Tau Inversion Recovery, STIR) is manifested by SC hyperintensity, since it enhances abnormal processes due to the short time inversion value, which suppresses the signal from fat. However, T2-STIR sequence has a lower signal-to-noise ratio and greater susceptibility to the spinal “imaging barriers” mentioned above. Therefore, this sequence has high sensitivity but low specificity for spinal lesions [19, 20].

As with cerebral infarction, T2-weighted images are sensitive to the total volume of tissue fluid in the SC. Therefore, signal intensity change appears only once significant vasogenic edema of the infarcted tissue has developed. Therefore, the SC ischemia lesion is not seen on T2-weighted MR images at the onset of clinical symptoms [6, 22]. In a study by K. Ne-deltchev et al., only 45% of patients with acute SC ischemia had signal intensity changes on T2-weighed MR images performed on day 1 of the onset of clinical symptoms [8].

М.М. Thurnher et al. assessed MRI findings in 23 patients with SCI: MR signals on T2-weighted MR images were not visualized in 3–4 hours but were seen in 8 hours after the onset of clinical symptoms [23]. According to S. Weidauer et al., slight signal change on T2-weighted MR images can be seen as early as in 3 hours but significant signal change is seen only in 12–24 hours after the onset of clinical symptoms [24]. Based on these observations, the authors suggested that MRI should be performed not earlier than 12 hours from the onset of clinical signs of myelopathy or later, since the infarction lesion is best visible in the su-bacute stage of its development [11].

Thus, basic MRI sequences have low sensitivity at the onset of SCI, when the accuracy of the differential diagnosis of myelopathy is especially important and critical. On the other hand, low sensitivity of T2-weighted images at the onset of SCI (i. e. no signal enhancement from the lesion and the development of edema) can be itself a useful differential diagnostic sign [16, 24].

However, T2 signal hyperintensity and SC edema are non-specific findings that can be also seen in patients with myelitis of various origin. In this context, diffusion MRI sequences are of key relevance [6, 23, 24].

Diffusion-weighted imaging (DWI) sequence, which has a high sensitivity to cerebral cytotoxic edema, is widely used in angioneurology to determine the most acute stage of cerebral infarction [2, 25]. High sensitivity of DWI for acute ischemic processes in the brain has been demonstrated in multiple studies. Diffusion and perfusion MRI is an important investigational tool in the acute phase of ischemic stroke, as it may differentiate reversible brain tissue damage from irreversible [25].

Experience with DWI in patients with SCI is limited. This is mainly related to technical difficulty with DWI in the spinal canal. Pulse sequences specifically designed for the spine and spinal cord are not commonly available and require optimization [23].

For DWI of the SC, single echoplanar imaging is used with a maximum b-factor of 600–1000 sec/mm2 and a slice thickness of 3 mm. In SCI patients, apparent diffusion coefficient varied from 0.23 to 0.9 × 103 mm2/s (Figure 1) [23].

 

Fig. 1. MR image of patient P. with SC infarction at Th11–Th12.

A) T2-weighted image, sagittal plane: intramedullary hyperintense elongated lesion (white arrows) at Th11–Th12;

В) Т2-STIR, sagittal plane: intramedullary hyperintense elongated lesion (white arrows) at Th11–Th12;

C) DWI, coronal plane: intramedullary hyperintense lesion of irregular shape at Th11–Th12 (white arrow), b = 800;

D) T2-weighted image, axial plane: hyperintense intramedullary lesion at Th11–Th12;

E) DWI, axial plane: intramedullary hyperintense lesion on the right at Th11–Th12 (blue arrows), b = 800;

F) DWI, axial plane, ADC map: diffusion restriction corresponding to the lesion on DWI (blue arrows), b = 800.

 

None of the studies established the exact time frames for the manifestation of diffusion changes in the SC substance. According to different authors, the average time between the onset of clinical symptoms and signal change on DWI is 3 to 4 hours [26]. In a study by М.М. Thurnher et al. in 23 SCI patients, persistent hyperintensity of the SC ischemia lesion on DWI was reported when MR images were obtained between 2 and 9 days [23]. In a study in 11 patients by N. Yadav et al., diffusion limitation was not seen during imaging on day 17 to 21 from the onset of clinical symptoms [27]. Therefore, larger studies are needed to establish the temporal threshold for diffusion changes on MRI in patients with SCI.

There is no doubt that DWI-MRI can help in identifying SCI at early stage. However, despite the use of techniques to reduce spatial distortion and improve the quality of the images, some technical challenges persist for DWI of the SC [26].

Quality of echoplanar DWI is reduced due to susceptibility artifacts and those related to spine magnetic field, which may result in false positive results [28]. Throughout the long echo sequence, phase errors will accumulate, resulting in spatial inconsistency in the reconstructed image. The longer the echo sequence and the higher the resolution, the more pronounced the distortions will be, which will be also amplified due to differences in the susceptibility of various spinal tissues (bones, intervertebral discs, cerebrospinal fluid, etc.) [16, 27].

Susceptibility distortions around the SC can lead to “pile-up” artifacts (hyperintensities) that can mimic cord infarction [23, 29]. To maintain sensitivity to ischemia, it was proposed to use higher b-factor values (> 600) [28].

Due to possible false-positive DWI results, it is recommended to supplement subsequent control MR studies with standard sequences (T2-WI, T2-STIR) [11].

According to M.X. Wang et al., diffusion weighted images at the spinal level are preferred in sagittal planes, as this view allows for larger coverage, shorter acquisition time, and less artifact [12].

Key MR features of vascular myeolpathy

Due to small size of the SC, its lesions are relatively small and visually indistinguishable on MRI, which definitely complicates the differential diagnosis of myelopathies. However, for some demyelinating disorders (multiple sclerosis, neuromyelitis optica spectrum disorder, acute disseminated encephalomyelitis), systemic inflammatory disorders (sarcoidosis), dysmetabolic disorders (vitamin B12 deficiency) and other processes, specific MR patterns have been described, which, together with the clinical and laboratory findings, allow establishing the correct diagnosis [30–33]. Accuracy of imaging can be improved by considering MR patterns typical for the acute and subacute stages of vascular myelopathy of arterial or venous origin.

MR features of spinal cord arterial infarction

Arterial infarction of SC tends to occur in “watershed” areas where collateral circulation is poor, which is likely to explain delayed signal increase on T2-WI and T2-STIR in the acute phase of SCI [34]. However, a literature review demonstrated the lack of consensus on the most common location of such areas (lower cervical segments, middle, lower thoracic segments, conus medullaris).

Studies by A.A. Skoromets et al. [1], J. Novy et al. [18], S. Weidauer et al. [24, 31] illustrated various models (types) of arterial ischemia of the SC, which reflect the vascular territory involved: the area of the anterior spinal artery (ASA) limited by the anterior horns and adjacent white matter on both sides (anterior type); the area of the posterior spinal arteries limited by the posterior columns, adjacent areas of the lateral columns and part of the posterior horns (posterior type); rarer sulcocommissural, central and transverse types.

In some cases of reduced collateral blood supply to the SC, the ischemic lesion can involve only the gray matter of the anterior horns due to a greater sensitivity of motor neurons to anoxia and the presence of a “watershed” area between the pial and sulcocommissural arteries. Over time, this morphological pattern leads to a typical MRI pattern described as “owl eye” or “snake eye” appearance on axial T2-weighed images [27, 31]. On sagittal T2-weighed images, this hypointense lesion corresponds to a pin-like or pencil-like appearance and usually involves more than 2 spine segments (Figure 2) [19].

 

Fig. 2. MR image of patient A. with arterial infarction of spinal cord at С2–С3, С3–С7.

A) T2-weighed image, sagittal plane: multifocal intramedullary hyperintense elongated lesion at C2–C3, C3–C7; the light-yellow line indicates the section at C3 (D), the purple line indicates the slice at the C5–C6 intervertebral disc level (Е);

B) Т2-STIR, sagittal plane: intramedullary hyperintense elongated lesion (white arrows) at C2–C3, C3–C7;

C) T1-WI, sagittal plane: multifocal intramedullary hypointense elongated lesion at C2–C3, C3–C7 (white arrows);

D) T2-weighed image, axial plane: intramedullary hyperintense lesion at C3 occupying the gray matter area (hologrey phenomenon, light yellow arrow);

E) T2-weighed image, axial plane: intramedullary hyperintense lesions at the intervertebral disc at C5–C6 (snake eyes phenomenon, purple arrows);

F) T1-WI, axial plane: intramedullary hypointense lesion at C3 (white arrow).

 

However, the “snake eye” appearance is not typical for SCI. Some other diseases that involve anterior horn motor neurons, such as motor neuron disease, spinal muscular atrophy [35], Hirayama disease [36], poliomyelitis and tick-borne encephalomyelitis, may also be associated with this MR sign [31–33].

It should be noted that the identification of specific MR patterns may have limitations in differential diagnosis, for example, with demyelinating lesions of the SC [34, 37]. In such cases, i. v. contrast enhanced brain MRI must be performed [24].

N.L. Zalewski et al. in their series of articles evaluated incidence of different MR patterns in 75 SCI patients [10, 17]. Signs of ischemia in the territory of the ASA with involvement of the anterior 2/3 of the SC and the “snake eye” or “pin” appearance was quite common (63–70% of cases). In almost half of the cases (46%), the hologrey phenomenon was observed on axial images, which corresponds to an increase in the T2 signal from the gray matter of the SC and, probably, reflects its greater vulnerability to hypoxia. Atypical T2-hyperintense anteromedial U- or V-shaped lesions were seen in 15–20% of cases. Lesions were often (68%) vertically extended (≥ 3 vertebral segments), extending from the thoracic region to the conus and were accompanied by edema of the SC substance (25%). In some cases, a perifocal increase in T2-weighted signal from the ASA indicated the presence of a thrombus or slow blood flow [10, 17].

N. Yasuda et al. demonstrated different MR patterns depending on the location and extent of aortal surgery (thoracic/abdominal/aortic arch replacement) [38], thus showing the importance of neuroimaging monitoring in this population.

Besides medullary ones, we should note extramedullary MR signs of arterial ischemia of the SC, such as vertebral body infarction, which is manifested by abnormal high signal from the bone marrow on T2-weighed images. This phenomenon can be explained by proximal occlusion of the artery leading to the vertebral body, intervertebral disc, and spinal cord [26, 37, 39]. According to S. Weidauer, this MR sign can appear from 8 hours to several days or weeks after the onset of clinical symptoms [31]. Its prevalence ranges from 14% to 44%, and it is more common with lesions in the territory of the ASA [27].

MR features of spinal venous insufficiency

Spinal arteriovenous fistulas are the most common vascular malformations of the spine (70%). Among those, the most common are spinal dural arteriovenous fistulas (SDAVFs) of thoracolumbar localization, which account for 70–85% of cases with an annual incidence of 5–10 cases/1 million [32].

The fistula drains directly into the intradural radicular vein and then into the perimedullary venous plexus. Enlarged serpentine perimedullary veins ascend along the SC. Due to insufficient venous egress into the epidural plexus, venous congestion develops, followed by medullary edema, which later can lead to decreased arterial perfusion and subacute/chronic ischemia with very non-specific clinical manifestations such as gait disturbances (myelogenous intermittent claudication), “saddleback” hypoesthesia, pain in the lower extremities, and dysfunction of pelvic organs [1, 19, 40].

MR signs of SDAVF reflect the pathophysiological pattern of venous hypertension: key signs include swelling of the lower thoracic and caudal segments of the SC with hyperintensity on T2-WI and hypointensity on T1-WI together with tortuosity of the dilated perimedullary veins of the SC usually on its dorsal surface. These serpentine veins appear as linear areas of flow void phenomenon on T2-WI or contrast-enhancing structures on post-contrast T1-WI (Figure 3). In case of severe edema of the SC, the veins may not be visualized due to the mass effect [40]. Limited, often well-defined lesions with a hypointense rim due to hemosiderin deposits can also be detected, and they are characterized by a heterogeneous hyperintense intralesional signal depending on the stage of hemorrhage on T2-weighted images [31, 41].

 

Fig. 3. MR image of patient V. with spinal venous insufficiency at Th9–Th11.

A) T2-WI, sagittal plane; B) T2-WI, axial plane: intramedullary hyperintense lesion of predominantly dorsal location at Th9–Th11 (light yellow arrow), hypointense dilated perimedullary vessels, mainly along the posterior surface of the SC at Th8–Th11 ("flow voids" phenomenon, white arrow).

 

N.L. Zalewski et al. demonstrated an additional MR pattern for SDAVF (termed the missing-piece sign), which is defined as an area of missing contrast enhancement in at least one or several SC segments amidst an intense area of contrast enhancement [42]. According to the authors, missing contrast enhancement in individual segments was likely to be related to the intact blood-cord barrier and better venous egress routes.

MR imaging of spinal cord vessels

Based on characteristics of the spinal cord ischemic lesion obtained using standard (T2, STIR) and diffusion MRI sequences, it should be considered whether the patient needs MR angiography of the CS.

In this context, selective spinal angiography (SSA) remains the diagnostic gold standard. SSA allows visualization of both normal angioarchitecture and various abnormalities of the arteries and veins of the SC. This method allows dynamic assessment of arterial inflows to the vascular myelopathy lesion, condition of the vessels directly in the lesion, and the features of the venous egress [1, 43, 44]. However, this invasive procedure can only be carried out in specialized centers by specialists in X-ray surgical diagnostics and treatment. Due to its technical difficulty and potential complications, the indication for SSA should be well considered and reserved for the cases where a vascular malformation is suspected (flow void phenomenon, i.e. a typical SC edema on T2, STIR), or secondly for preoperative imaging of the vascular anatomy or supply in cases of spinal or medullary tumors, or aortic disease [44].

Contrast spinal MR angiography (CMRA) can be an alternative option or a method preceding SSA that allows clarifying the origin, location, and volume of previously identified vascular change [45]. With comparable sensitivity to SSA, this method can be used for dynamic SC MR-angiography, including perioperative setting [44]. Angiodynamic analysis of the vascular myelopathy lesion is an advantage of CMRA. Dynamic CMRA is also useful in detecting dissection and thrombosis of large (aorta) and small (vertebral) arteries (Figure 4) [21, 45].

 

Fig. 4. MRI and angiography of patient S. with spinal venous insufficiency at Th8–Th10, Th11–Th12.

A) T2-SPAIR (SPectral Attenuated Inversion Recovery), sagittal plane: centromedullary hyperintense lesion at Th8–Th10 (white arrows), sharply hypointense lesion probably caused by hemosiderin deposition at Th11–Th12 (purple arrow), dilated straight vessel adjacent to the spinal cord conus (red arrow);

B) SMRA, coronal plane: under contrast enhancement along the entire posterior surface of the SC, a dilated convoluted vessel (brown arrow) is seen, into which the wide radicular vein flows from the left intervertebral foramen Th10–Th11 (red arrow);

C) selective spinal angiography of the left common lumbar artery (L4, L5): early arteriovenous discharge from the radiculospinal artery into the dilated vein of the cauda equina (red arrow) with contrasting of the spinal veins in the cranial direction (brown arrow).

 

CMRA allows visualization of blood flow in the arterial, venous and delayed phases. Therefore, 3D and 4D CMRA is an effective technique for visualization of vascular malformations and arteriovenous fistulas, such as SDAVFs [45]. These sequences allow determining the exact location of the arteriovenous fistula, its interaction with other vascular structures, and the course of serpentine perimedullary vessels [33]. In a study by А. Lindenholz et al., CE-MRA correctly localized the SDAVF in 43 of the 53 cases (81%) [46].

In some cases, such as in patients with artificial pacemakers, other MR-incompatible devices, or severe claustrophobia, MRI cannot be performed for diagnostics of vascular myelopathy. These patients should have CT angiography of the aorta and its branches, which allows identifying atherosclerotic damage to the walls of the major vessels, the presence of local narrowings and dissections that impede the SC blood supply [12, 43, 44].

Promising approaches in MR imaging of vascular myelopathy

Analysis of intramedullary lesions is challenging if standard MR sequences are used. Determining the nature of myelopathy and distinguishing acute ischemic lesions from hyperacute and subacute ones remains challenging from the clinical and radiological points of view.

Use of ultra-high-field MRI scanners (≥ 3 T) has an obvious advantage of more detailed imaging of small structures, which is especially valuable in visualization of the SC and its vessels for primary or preoperative diagnostics [20]. However, the choice of a 3 T MR scanner for SCI is controversial, as more detailed visualization of the lesion may be attenuated by the presence of the aforementioned “imaging barriers” [47].

Diffusion tensor imaging (DTI) is an additional sequence that can be performed at 1.5 and 3 T. This method allows non-invasive mapping of molecular diffusion in biological tissues. Similarly to DWI, DTI uses a b-factor range of 600–800 mm/sec, mainly because of the cranial-caudal direction of water molecule diffusion in the SC [21, 29, 48].

The relatively small transverse dimensions and elongated shape of the SC is a major diagnostic challenge for DTI in SCI imaging. The limited volume of fiber tracts naturally leads to the need for high spatial resolution [47].

The above-mentioned studies demonstrated the increasingly important diagnostic role of DTI owing to its ability to assess the white matter microstructural integrity via measurements of quantitative diffusion indices, such as cross-sectional area as an indicator of SC atrophy, fractional anisotropy to assess axonal integrity, magnetization transfer coefficient as an indicator of demyelination, and mean diffusion in the ischemic lesion and perifocal areas [49]. At 3T or higher field strengths, T2-weighted imaging of the SC provides high resolution and strong contrast between gray matter and white matter, allowing segmentation between these structures and calculation of their cross-sectional area (Figure 5) [50].

 

Fig. 5. 3D DTI color-coded tractography map of patient V. with spinal venous insufficiency at Th9–Th11.

Conducting fibers at Th9–Th11 are highlighted in blue, demonstrating abnormal spatial orientation of the fibers in the ischemic lesion (blue arrow), fractional anisotropy 0.46 ± 0.18, apparent diffusion coefficient 0.79 ± 0.15 × 103 mm2/sec.

 

For the axial imaging of SC several authors suggested supplementing the MRI protocol with Т2*-gradient recalled echo, which has a high sensitivity to paramagnetic blood products (hemosiderin) [19].

Conclusion

Despite the lack of uniform diagnostic protocols, MRI is the method of choice for the diagnosis and differential diagnosis of vascular and other myelopathies. Diagnostic efficacy of MRI directly depends on spatial resolution and signal/noise ratio of the scanner.

Patterns described do not sufficiently increase the specificity of the radiological picture of the acute period of SC infarction, so the MR examination protocol should be elaborated. DWI is an additional sequence that allows establishing the ischemic nature of myelopathy. Average time to normalization of DWI signal is 2 to 3 weeks, which is essentially a “diagnostic window” for confirming/excluding the diagnosis and starting treatment.

If included in a comprehensive diagnostic protocol, dynamic angiographic methods, such as CMRA, allow visualization of thrombosis of the aorta and its large branches or SDAVF and other spinal arteriovenous fistulas, contributing to their early surgical correction.

Thus, the optimal technical protocol for MRI for 1.5 and 3 T scanners in patients with suspected arterial vascular myelopathy is the following [19, 21, 44]:

  • Sagittal spin-echo T2-WI;
  • Axial spin-echo T2-WI;
  • Sagittal spin-echo T2 STIR;
  • Sagittal and axial DWI (b = 600–800);
  • Axial T2*-gradient recalled echo;
  • Pre-contrast sagittal spin-echo T1-WI;
  • 3D dynamic three-phase contrast CMRA;
  • Post-contrast sagittal spin-echo T1-WI.

Slice thickness is 3 mm.

Differential diagnostic aspects of identifying vascular lesions necessitate comparison of sagittal and axial images of the SC. The advantage of the sagittal plane is greater coverage with shorter acquisition times. The axial plane allows visualizing the specific location of the lesion across the diameter of the SC and the symmetry of MR signal change in the case of ischemia in the territory of the ASA.

We should highlight the issue of introducing mandatory neuroimaging monitoring including diffusion and angiodynamic MR scanning modes, in particular, during surgery on the aorta. This approach seems to be extremely important, since it will allow timely preventive measures to be taken against potential myeloischemic disorders in this patient population.

Investigation of microstructural ischemic lesions of the SC with DTI is of great clinical interest. Assessing the integrity of the SC tracts under the influence of various causes of myeloischemia will facilitate the selection of an appropriate treatment. Additional studies to investigate capabilities of DTI with substantiated results will allow including this method in an expanded examination protocol.

In general, there are still many unresolved issues regarding the visualization of ischemic lesions of the SC. There are no generally accepted approaches and protocols for MRI diagnostics of vascular myelopathies, and differential diagnostics is challenging. The information presented in this review can be a guideline in routine clinical practice and a basis for further research and development of a unified approach to diagnosing vascular myelopathy in Russia.

1 Not used in Russia.

×

About the authors

Grigory V. Ponomarev

Pavlov First Saint Petersburg State Medical University

Author for correspondence.
Email: grigoryponomarev@yandex.ru
ORCID iD: 0000-0002-6219-8855

Cand. Sci. (Med.), assistant, Department of neurology

Россия, Saint Petersburg

Andrey O. Agafonov

Pavlov First Saint Petersburg State Medical University

Email: agafonov@spbgmu.ru
ORCID iD: 0000-0002-0261-3527

Cand. Sci. (Med.), Assoc. Prof., Department of radiology and radiation medicine

Россия, Saint Petersburg

Nikolay L. Barilyak

Vsevolozhsk Clinical Interdistrict Hospital

Email: barilyak2502@gmail.com
ORCID iD: 0000-0002-8174-2510

neurologist

Россия, Vsevolozhsk

Alexander V. Amelin

Pavlov First Saint Petersburg State Medical University

Email: avamelin@mail.ru
ORCID iD: 0000-0001-6437-232X

Dr. Sci. (Med.), Prof., Department of neurology

Россия, Saint Petersburg

Alexander A. Skoromets

Pavlov First Saint Petersburg State Medical University

Email: askoromets@gmail.com
ORCID iD: 0000-0002-5884-3110

Dr. Sci. (Med.), Prof., Academician of the Russian Academy of Sciences, Head, Department of neurology

Россия, Saint Petersburg

References

  1. Скоромец А.А., Афанасьев В.В., Скоромец А.П., Скоромец Т.А. Сосудистые заболевания спинного мозга: руководство для врачей. СПб.; 2019. 314 с. Skoromets A.A., Afanas'ev V.V., Skoromets A.P., Skoromets T.A. Vascular diseases of the spinal cord: a guide for doctors. St. Petersburg; 2019. 314 p. (In Russ.)
  2. Трофимова Т.Н., Ананьева Н.И., Назинкина Ю.В. и др. Нейрорадиология. СПб.; 2009. 288 с. Trofimova T.N., Anan'eva N.I., Nazinkina Yu.V. et al. Neuroradiology. St. Petersburg; 2009. 288 p. (In Russ.)
  3. Rumboldt Z., Castillo M., Huang B. et al. (eds.) Brain imaging with MRI and CT: an image pattern approach. Cambridge; 2012. 428 p.
  4. Morgan W. Spinal MRI for musculoskeletal clinicians. Introduction to systematic analysis of the spinal MRI. Independent; 2014. 130 p.
  5. Sacco R.L., Kasner S.E., Broderick J.P. et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(7):2064–2089. doi: 10.1161/STR.0b013e318296aeca
  6. Küker W., Weller M., Klose U. et al. Diffusion-weighted MRI of spinal cord infarction–high resolution imaging and time course of diffusion abnormality. J. Neurol. 2004;251(7):818–824. doi: 10.1007/s00415-004-0434-z
  7. Lyders E.M., Morris P.P. A case of spinal cord infarction following lumbar transforaminal epidural steroid injection: MR imaging and angiographic findings. Am. J. Neuroradiol. 2009;30(9):1691–1693. doi: 10.3174/ajnr.A1567
  8. Nedeltchev K., Loher T.J., Stepper F. et al. Long-term outcome of acute spinal cord ischemia syndrome. Stroke. 2004;35(2):560–565. doi: 10.1161/01.STR.0000111598.78198.EC
  9. Qureshi A.I., Afzal M.R., Suri M.F.K. A population-based study of the incidence of acute spinal cord infarction. J. Vasc. Interv. Neurol. 2017;9(4):44–48.
  10. Zalewski N.L., Rabinstein A.A., Krecke K.N. et al. Characteristics of spontaneous spinal cord infarction and proposed diagnostic criteria. JAMA Neurol. 2019;76(1):56–63. doi: 10.1001/jamaneurol.2018.2734
  11. Kim B.R., Park K.S., Kim H.J. et al. Features of non-traumatic spinal cord infarction on MRI: Changes over time. PLoS One. 2022;17(9):e0274821. doi: 10.1371/journal.pone.0274821
  12. Wang M.X., Smith G., Albayram M. Spinal cord watershed infarction: Novel findings on magnetic resonance imaging. Clin. Imaging. 2019;55:71-75. doi: 10.1016/j.clinimag.2019.01.023
  13. Jakubowicz-Lachowska D., Tarasiuk J., Kapica-Topczewska K. et al. Future challenges of spinal cord infarction treatment. Neurol. Neurochir. Pol. 2020;54(2):209–210. doi: 10.5603/PJNNS.a2020.0023
  14. Bax F., Gigli G.L., Iaiza F. et al. Spontaneous spinal cord ischemia during COVID-19 infection. J. Neurol. 2021;268(11):4000–4001. doi: 10.1007/s00415-021-10574-x
  15. Romi F., Naess H. Spinal cord infarction in clinical neurology: a review of characteristics and long-term prognosis in comparison to cerebral infarction. Eur. Neurol. 2016;76(3-4):95–98. doi: 10.1159/000446700
  16. Alblas C.L., Bouvy W.H., Lycklama À Nijeholt G.J., Boiten J. Acute spinal-cord ischemia: evolution of MRI findings. J. Clin. Neurol. 2012;8(3):218–223. doi: 10.3988/jcn.2012.8.3.218
  17. Zalewski N.L., Rabinstein A.A., Krecke K.N. et al. Spinal cord infarction: Clinical and imaging insights from the periprocedural setting. J. Neurol. Sci. 2018;388:162–167. doi: 10.1016/j.jns.2018.03.029
  18. Novy J., Carruzzo A., Maeder P. et al. Spinal cord ischemia: clinical and imaging patterns, pathogenesis, and outcomes in 27 patients. Arch. Neurol. 2006;63(8):1113–1120. doi: 10.1001/archneur.63.8.1113
  19. Da Ros V., Picchi E., Ferrazzoli V. et al. Spinal vascular lesions: anatomy, imaging techniques and treatment. Eur. J. Radiol. Open. 2021;8:100369. doi: 10.1016/j.ejro.2021.100369
  20. Alcaide-Leon P., Pauranik A., Alshafai L. et al. Comparison of sagittal FSE T2, STIR, and T1-weighted phase-sensitive inversion recovery in the detection of spinal cord lesions in MS at 3T. AJNR Am. J. Neuroradiol. 2016;37(5):970–975. doi: 10.3174/ajnr.A4656
  21. Vargas M.I., Boto J., Meling T.R. Imaging of the spine and spinal cord: an overview of magnetic resonance imaging (MRI) techniques. Rev. Neurol. (Paris). 2021;177(5):451–458. doi: 10.1016/j.neurol.2020.07.005
  22. Masson C., Pruvo J.P., Meder J.F. et al. Spinal cord infarction: clinical and magnetic resonance imaging findings and short term outcome. J. Neurol. Neurosurg. Psychiatry. 2004;75(10):1431–1435. doi: 10.1136/jnnp.2003.031724
  23. Thurnher M.M., Bammer R. Diffusion-weighted MR imaging (DWI) in spinal cord ischemia. Neuroradiology. 2006;48(11):795–801. doi: 10.1007/s00234-006-0130-z
  24. Weidauer S., Nichtweiß M., Hattingen E. et al. Spinal cord ischemia: aetiology, clinical syndromes and imaging features. Neuroradiology. 2015;57(3):241–257. doi: 10.1007/s00234-014-1464-6
  25. Warach, S. Use of diffusion and perfusion magnetic resonance imaging as a tool in acute stroke clinical trials. Curr. Control Trials Cardiovasc. Med. 2001;2(1):38–44. doi: 10.1186/cvm-2-1-038
  26. Costamagna G., Meneri M., Abati E. et al. Hyperacute extensive spinal cord infarction and negative spine magnetic resonance imaging: a case report and review of the literature. Medicine (Baltimore). 2020;99(43):e22900. doi: 10.1097/MD.0000000000022900
  27. Yadav N., Pendharkar H., Kulkarni G.B. Spinal cord infarction: clinical and radiological features. J. Stroke Cerebrovasc. Dis.2018;27(10):2810–2821. doi: 10.1016/j.jstrokecerebrovasdis.2018.06.008
  28. Loher T.J., Bassetti C.L., Lövblad K.O. et al. Diffusion-weighted MRI in acute spinal cord ischaemia. Neuroradiology. 2003;45(8):557–561. doi: 10.1007/s00234-003-1023-z
  29. Vargas M.I., Delattre B..MA., Boto J. et al. Advanced magnetic resonance imaging (MRI) techniques of the spine and spinal cord in children and adults. Insights Imaging. 2018;9(4):549–557. doi: 10.1007/s13244-018-0626-1
  30. Краснов В.С., Прахова Л.Н., Тотолян Н.А. Современные представления о диагностике и терапии обострений заболеваний спектра оптиконевромиелита. Неврология, нейропсихиатрия, психосоматика. 2022;14(5):69–76. Krasnov V.S., Prakhova L.N., Totolyan N.A. Current view on the diagnosis and treatment of neuromyelitis optica spectrum disorders exacerbations. Nevrologiya, neiropsikhiatriya, psikhosomatika. 2022;14(5):69–76. doi: 10.14412/2074-2711-2022-5-69-76
  31. Weidauer S., Wagner M., Nichtweiß M. Magnetic Resonance Imaging and Clinical Features in Acute and Subacute Myelopathies. Clin. Neuroradiol. 2017;27(4):417–433. doi: 10.1007/s00062-017-0604-x
  32. Kranz P.G., Amrhein T.J. Imaging approach to myelopathy: Acute, Subacute, and Chronic. Radiol. Clin. North Am. 2019;57(2):257–279. doi: 10.1016/j.rcl.2018.09.006
  33. Sarbu N., Lolli V., Smirniotopoulos J.G. Magnetic resonance imaging in myelopathy: a pictorial review. Clin. Imaging. 2019;57:56–68. doi: 10.1016/j.clinimag.2019.05.002
  34. Kister I., Johnson E., Raz E. et al. Specific MRI findings help distinguish acute transverse myelitis of neuromyelitis optica from spinal cord infarction. Mult. Scler. Relat. Disord. 2016;9:62–67. doi: 10.1016/j.msard.2016.04.005
  35. Lebouteux M-V., Franques J., Guillevin R. et al. Revisiting the spectrum of lower motor neuron diseases with snake eyes appearance on magnetic resonance imaging. Eur. J. Neurol. 2014;21(9):1233–1241. doi: 10.1111/ene.12465
  36. Desai J.A., Melanson M. Teaching neuroimages: anterior horn cell hyperintensity in Hirayama disease. Neurology. 2011;77(12):e73. doi: 10.1212/WNL.0b013e31822f02d0
  37. Hsu J.L., Cheng M.Y., Liao M.F. et al. A comparison between spinal cord infarction and neuromyelitis optica spectrum disorders: clinical and MRI studies. Sci. Rep. 2019;9(1):7435. doi: 10.1038/s41598-019-43606-8
  38. Yasuda N., Kuroda Y., Ito T. et al. Postoperative spinal cord ischaemia: magnetic resonance imaging and clinical features. Eur. J. Cardiothorac. Surg. 2021;60(1):164–174. doi: 10.1093/ejcts/ezaa476
  39. Vargas M.I., Gariani J., Sztajzel R. et al. Spinal cord ischemia: practical imaging tips, pearls, and pitfalls. Am. J. Neuroradiol. 2015;36(5):825–830. doi: 10.3174/ajnr.A4118
  40. Kiyosue H., Matsumaru Y., Niimi Y. et al. Angiographic and clinical characteristics of thoracolumbar spinal epidural and dural arteriovenous fistulas. Stroke. 2017;48(12):3215–3222. doi: 10.1161/STROKEAHA.117.019131
  41. Vuong S.M., Jeong W.J., Morales H. et al. Vascular diseases of the spinal cord: infarction, hemorrhage, and venous congestive myelopathy. Semin. Ultrasound CT MR. 2016;37(5):466–481. doi: 10.1053/j.sult.2016.05.008
  42. Zalewski N.L., Rabinstein A.A., Brinjikji W. et al. Unique gadolinium enhancement pattern in spinal dural arteriovenous fistulas. JAMA Neurol. 2018;75(12):1542–1545. doi: 10.1001/jamaneurol.2018.2605
  43. Brinjikji W., Yin R., Nasr D.M. et al. Spinal epidural arteriovenous fistulas. J. Neurointerv. Surg. 2016;8(12):1305–1310. doi: 10.1136/neurintsurg-2015-012181
  44. Vargas M.I., Barnaure I., Gariani J. et al. Vascular imaging techniques of the spinal cord. Semin. Ultrasound CT MR. 2017;38(2):143–152. doi: 10.1053/j.sult.2016.07.004
  45. Pattany P.M., Saraf-Lavi E., Bowen B.C. MR angiography of the spine and spinal cord. Top. Magn. Reson. Imaging. 2003;14(6):444–460. doi: 10.1097/00002142-200312000-00003
  46. Lindenholz A., TerBrugge K.G., van Dijk J.M. et al. The accuracy and utility of contrast-enhanced MR angiography for localization of spinal dural arteriovenous fistulas: the Toronto experience. Eur. Radiol. 2014. 24(11): 2885–2894. doi: 10.1007/s00330-014-3307-6
  47. Vargas M.I., Drake-Pérez M., Delattre B.M.A. et al. Feasibility of a synthetic MR imaging sequence for spine imaging. AJNR Am. J. Neuroradiol. 2018;39(9):1756–1763. doi: 10.3174/ajnr.A5728
  48. Беленький В.В., Козырева Е.А., Плахотина Н.А. и др. Диагностические возможности спинальной МРТ-трактографии и спинальной МРТ-ангиографии у больного спастической диплегией. Журнал неврологии и психиатрии им. С.С. Корсакова. 2022;122(7):151–155. Belenky V.V., Kozireva E.A., Plakhotina N.A. et al. Utility of spinal MRI tractography and spinal MRI angiography in the diagnosis of spastic diplegia. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2022;122(7):151–155. doi: 10.17116/jnevro2022122071151
  49. Cheng S.J., Tsai P.H., Lee Y.T. et al. Diffusion tensor imaging of the spinal cord. Magn. Reson. Imaging Clin. N. Am. 2021;29(2):195–204. doi: 10.1016/j.mric.2021.02.002
  50. Martin A.R., De Leener B., Cohen-Adad J. et al. A novel MRI biomarker of spinal cord white matter injury: T2*-weighted white matter to gray matter signal intensity ratio. AJNR Am. J. Neuroradiol. 2017;38(6):1266–1273. doi: 10.3174/ajnr.A5162

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. MR image of patient P. with SC infarction at Th11–Th12.

Download (719KB)
3. Fig. 2. MR image of patient A. with arterial infarction of spinal cord at С2–С3, С3–С7.

Download (749KB)
4. Fig. 3. MR image of patient V. with spinal venous insufficiency at Th9–Th11.

Download (408KB)
5. Fig. 4. MRI and angiography of patient S. with spinal venous insufficiency at Th8–Th10, Th11–Th12.

Download (797KB)
6. Fig. 5. 3D DTI color-coded tractography map of patient V. with spinal venous insufficiency at Th9–Th11.

Download (486KB)

Copyright (c) 2024 Ponomarev G.V., Agafonov A.O., Barilyak N.L., Amelin A.V., Skoromets A.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-83204 от 12.05.2022.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies